Frequency of primary and secondary outcomes
Outcome . | G1, n (%) . | G2 neonates, n (%) . | G2 non-neonates, n (%) . | P value . |
---|---|---|---|---|
PTS | .007 | |||
No | 3 (13%) | 21 (84%) | 56 (51%) | |
Mild | 14 (61%) | 4 (16%) | 52 (47%) | |
Moderate | 6 (26%) | 0 | 2 (2%) | |
Severe | 0 | 0 | 0 | |
DVT resolution | .35 | |||
Complete resolution | 7 (30%) | 10 (40%) | 38 (36%) | |
Partial resolution | 13 (56%) | 9 (36%) | 37 (35%) | |
No resolution or extension | 3 (13%) | 6 (24%) | 31 (29%) | |
DVT recurrence | 3 (13%) | 0 | 15 (14%) | .12 |
PE | — | |||
Suspected | 4 (17%) | 0 | 8 (7%) | |
Confirmed | 0 | 0 | 3 (2.7%) |
Outcome . | G1, n (%) . | G2 neonates, n (%) . | G2 non-neonates, n (%) . | P value . |
---|---|---|---|---|
PTS | .007 | |||
No | 3 (13%) | 21 (84%) | 56 (51%) | |
Mild | 14 (61%) | 4 (16%) | 52 (47%) | |
Moderate | 6 (26%) | 0 | 2 (2%) | |
Severe | 0 | 0 | 0 | |
DVT resolution | .35 | |||
Complete resolution | 7 (30%) | 10 (40%) | 38 (36%) | |
Partial resolution | 13 (56%) | 9 (36%) | 37 (35%) | |
No resolution or extension | 3 (13%) | 6 (24%) | 31 (29%) | |
DVT recurrence | 3 (13%) | 0 | 15 (14%) | .12 |
PE | — | |||
Suspected | 4 (17%) | 0 | 8 (7%) | |
Confirmed | 0 | 0 | 3 (2.7%) |